Pharmacy News
July 19, 2021
July 16, 2021
- Opioid Dependence Drug Recalled for Subpotency
- Over 88,000 Anti-Inflammatory Injections Recalled
- Teva Initiates Voluntary Nationwide Recall of One Lot of Topotecan Injection 4 mg/4 mL (1 mg/mL) Due to Presence of Particulate Matter
July 12, 2021
July 2, 2021
- FDA alerts health care professionals and patients to a voluntary recall of varenicline (Chantix) to the warehouse level
- Diabetes Tablet Recalled for NDMA
July 1, 2021
June 27, 2021
June 21, 2021
June 17, 2021
June 16, 2021
June 14, 2021
June 10, 2021
June 8, 2021
- Class II Recall Notification: BusPIRone Hydrochloride 15 mg tablets manufactured by Oxford Pharmaceuticals
- Class II Recall Notification: Micardis Tablets manufactured by Boehringer Ingelheim Pharmaceuticals, Inc.
June 7, 2021
June 2, 2021
May 27, 2021
- Subpotent Antibiotic Recalled
- Class II Recall Notification: Guardian Sensor (3), GS3 5PK 2L US, Medtronic REF: MMT-7020A
- Class II Recall Notification: Guardian Sensor (3), GS3 5PK US, Medtronic REF: MMT-7020LA
- Class II Recall Notification: Medtronic REF: MMT-7008A, Enlite Glucose Sensor, ENLITE PLUS 5PK 23L 1CL, ENLT PLUS 5PK 2L 1CL PR
- Class II Recall Notification: Guardian Sensor (3), GS3 5PK US GC, Medtronic REF: MMT-7020GA
May 19, 2021
May 5, 2021
- Hospira Issues A Voluntary Nationwide Recall for One Lot of Sterile Water for Injection, USP, Due to the Potential Presence of Visible Particulate
- Hospira Issues A Voluntary Nationwide Recall for One Lot of 0.5% Bupivacaine Hydrochloride Injection, USP and One Lot of 1% Lidocaine HCl Injection, USP Due to Mislabeling
- Preferred Pharmaceuticals, Inc. Issues a Voluntary Recall of Select Bottles of Cephalexin for Oral Suspension
- PD-Rx Pharmaceuticals, Inc. Issues a Voluntary Recall of Select Bottles of Losartan Potassium Tablets
April 30, 2021
April 28, 2021
April 27, 2021
April 22, 2021
- Class II Recall Notification: Itraconazole Capsules, 100mg Manufactured by Jubilant Cadista Pharmaceuticals, Inc.
- Class II Recall Notification: Cefprozil for Oral Suspension USP, 250mg/5mL by Lupin Limited
April 21, 2021
April 14, 2021
- Class II Recall Notification: Mometasone Furoate Topical Solution, USP, 0.1%, (Lotion) manufactured by Cosette Pharmaceuticals, Inc.
- Class II Recall: Neomycin Sulfate Tablets, USP 500mg by X-Gen Pharmaceuticals Inc.
- Class II Recall: Ganirelix Acetate Injection, 250mcg/0.5mL by Sun Pharmaceuticals Inc.
April 7, 2021
April 5, 2021
April 1, 2021
- Apotex Corp. Issues Voluntary Nationwide Recall of Guanfacine Extended-Release Tablets 2mg due to trace amounts of Quetiapine Fumarate
- Proton Pump Inhibitor Recalled
- Irrigation Solution Recalled
March 26, 2021
March 25, 2021
- Alembic Pharmaceuticals Limited Issues Voluntary Nationwide Recall of Telmisartan Tablets, USP, 20 mg Due to Label Mix-Up
- Consumer-Level Withdrawal Notification: Gamunex®-C 10% manufactured by Grifols (PDF)
- Zydus Pharmaceuticals (USA) Inc. Issues Voluntary Nationwide Recall of Acyclovir Sodium Injection, 50 mg/mL Due to Crystallization
March 16, 2021
- Class II Recall Notification: Progesterone 200 mg capsules manufactured by Dr. Reddy
- Class II Recall Notification: Famotidine 40 mg tablets manufactured by Aurobindo
March 12, 2021
March 10, 2021
March 5, 2021
March 3, 2021
- Class I Recall Notification: Cisatracurium Besylate Injection, 10 mg per 5 mL manufactured by Meitheal Pharmaceuticals, Inc.
- Class II Recall Notification: Imatinib Mesylate 100 mg Tablets, 90 Count Bottle manufactured by Dr. Reddy’s
February 26, 2021
- Vertigo Tablets Recalled in Two States
- Dr. Reddy’s Recalls Prescription Drug Blister Packages
- Voluntary Withdrawal of Two Lots of Gamunex-C 10% (Lot Number A1GLE01532) (Lot Number A1GLE01542)
February 13, 2021
- BRP Spironolactone tablets Consumer-Level Recall
February 12, 2021
February 2, 2021
- Class II Recall: Nortriptyline HCl Capsules by Taro Pharmaceuticals U.S.A., Inc.
- Apotex Corp. Issues Voluntary Nationwide Recall of Enoxaparin Sodium Injection, USP Due to Mislabeling of Syringe Barrel Measurement Markings
- Class I Recall Notification: Ketorolac Tromethamine 30 mg/1 mL Injection manufactured by Fresenius Kabi USA, LLC
January 28, 2021
January 27, 2021
January 15, 2021
January 8, 2021
- Combination Antibiotic Recalled Over Sterility Concerns
- Pain Medication Recalled
- Antibiotic Recalled
January 4, 2021
December 31, 2020
December 20, 2020
December 29, 2020
December 23, 2020
December 18, 2020
December 17, 2020
- Leukemia Drug Recalled
- Chemo Injection Recalled
- Chemotherapy Tablets Recalled
- Chemotherapy Drug Recalled
December 10, 2020
December 9, 2020
- AvKARE Issues Voluntary Nationwide Recall of Sildenafil 100mg Tablets and Trazodone 100mg Tablets Due to Product Mix-Up
- Torrent Pharmaceuticals Limited Issues Voluntary Nationwide Recall of Anagrelide Capsules, USP Due to Dissolution Test Failure
December 3, 2020
December 2, 2020
November 25, 2020
November 19, 2020
November 13, 2020
November 9, 2020
November 6, 2020
November 3, 2020
November 2, 2020
October 28, 2020
October 17, 2020
October 16, 2020
October 8, 2020
October 5, 2020
September 23, 2020
September 21, 2020
September 18, 2020
- Subpotent Antibiotic Recalled
- Acella Pharmaceuticals, LLC Issues Voluntary Nationwide Recall of Two Lots of NP Thyroid®, Thyroid Tablets, USP Due to Sub Potency
September 9, 2020
September 3, 2020
- Class I Recall for Anticoagulant
- Antibiotic Recalled
- Narcotic Pain Injection Recalled
- Consumer-Level Recall of Nature-Throid® and WP Thyroid® Tablets Manufactured by RLC Labs®
September 1, 2020
August 28, 2020
August 26, 2020
- Sanofi-Aventis U.S. LLC
- Lannett Company, Inc.
- The Calvin Scott & Company:
August 21, 2020
August 19, 2020
- SCA Pharmaceuticals (SCA) Is Issuing a Voluntary Nationwide Recall of Heparin Sodium Compounded Products Due to Incorrect Preservative (Benzyl Alcohol)
- Bayshore Pharmaceuticals, LLC Issues Voluntary Nationwide Recall of Metformin Hydrochloride Extended-Release Tablets USP, 500 mg and 750 mg Due to the Detection of N-Nitrosodimethylamine (NDMA) Impurity
August 14, 2020
August 7, 2020
August 6, 2020
July 29, 2020
July 24, 2020
July 23, 2020
July 14, 2020
July 9, 2020
- Two More Firms Recall Diabetes Drug
- Two Children’s Meds Recalled
- Braun Recalling Heparin Products
On July 9, 2020, CVS Caremark Mail Service received a consumer-level withdrawal notice from McKesson regarding Heparin Sodium in 5% Dextrose Injection manufactured by B Braun Medical Inc. This withdrawal was issued as part of ongoing changes which BBMI is performing to ensure their Heparin in Dextrose products meet USP requirements for Anti-Factor IIa potency throughout the labeled product shelf-life, BBMI is incorporating revisions to internal manufacturing requirements. Out of an abundance of caution, BBMI is withdrawing non-expired batches of those Heparin in Dextrose products which were produced prior to implementation of these changes. This withdrawal affects select Heparin Sodium in 5% Dextrose Injection products. - Osteoarthritis Injection Recalled
July 8, 2020
- Mylan Initiates Voluntary Nationwide Recall of One Lot of Daptomycin for Injection, Due to The Presence of Particulate
- Lupin Pharmaceuticals, Inc. Issues Voluntarily Nationwide Recall of Metformin Hydrochloride Extended-Release Tablets, 500mg and 1000mg Due to the Detection of N-Nitrosodimethylamine (NDMA) Impurity
July 6, 2020
July 2, 2020
- Diabetes Drug Recall Grows
- Label Mistake Prompts Antipsychotic Recall
- Major Pharmaceuticals Issues a Consumer-Level Recall of Metformin Extended-Release Tablets
On July 2, 2020, it was announced that Major Pharmaceuticals issued a consumer-level recall on Metformin Hydrochloride Extended-Release 500mg Tablets, 10×10 Unit Dose with NDC #00904-5794-61. The recall was issued due to one lot of Metformin being tested and showed results for NDMA levels in excess of the Acceptable Daily Intake Limit. This recall affects lot number T-02134 with expiration date 09/2020.
June 26, 2020
June 19, 2020
- GSK Consumer Healthcare Issues Voluntary Nationwide Recall of Children’s Robitussin® Honey Cough and Chest Congestion DM and Children’s Dimetapp® Cold and Cough Due to Dosing Cups Missing Some Graduation Markings
- Class I, II Recalls for Pain Injection
- Antibiotic Pills Recalled
June 17, 2020
June 12, 2020
June 11, 2020
- Lupin Pharmaceuticals, Inc. Issues Voluntarily Nationwide Recall of One Lot of Metformin Hydrochloride Extended-Release Tablets USP, 500mg Due to the Detection of N-Nitrosodimethylamine (NDMA)
- AvKARE Issues Consumer-Level Recall of Metformin Hydrochloride Extended-Release 500mg and 750mg Tablets
June 5, 2020
- Marksans Pharma Limited Issues Voluntary Nationwide Recall of Metformin Hydrochloride Extended-Release Tablets, USP 500mg, Due to the Detection of N-Nitrosodimethylamine (NDMA)
- Teva Pharmaceuticals USA, Inc. Initiates Voluntary Nationwide Recall of Metformin Hydrochloride Extended-Release Tablets USP 500 mg and 750 mg Due to Detection of N-Nitrosodimethylamine (NDMA)
June 3, 2020
June 2, 2020
June 1, 2020
May 28, 2020
May 27, 2020
May 22, 2020
May 15, 2020
May 12, 2020
May 11, 2020
May 8, 2020
- ICU Medical Issues a Voluntary Nationwide Recall of Lactated Ringer’s Injection, USP Due to the Presence of Particulate Matter
- Class I Recall Issued for Intravenous Antibiotic
- CU Medical Issues a Voluntary Nationwide Recall of Lactated Ringer’s Injection, USP Due to the Presence of Particulate Matter
- Antacid Recalled
May 1, 2020
April 29, 2020
April 24, 2020
April 21, 2020
- Voluntary Recall Notice for BD PosiFlush™ SF Saline Flush Syringes
- B. Braun Medical Inc. Issues Voluntary Nationwide Recall of One (1) Lot of Ceftazidime for Injection USP and Dextrose Injection USP (50 mL), Duplex Container Due to Out-of-Specification Results for High Molecular Weight Polymers
- Trividia Health, Inc. Issues Nationwide Voluntary Recall for an Isolated TRUE METRIX AIR Blood Glucose Meter with Serial Number TA1548753
April 20, 2020
- Fresenius Kabi Issues Voluntary Nationwide Recall of 13 Lots of Ketorolac Tromethamine Injection, USP Due to the Presence of Particulate Matter in Reserve Samples
- Avet Pharmaceuticals Voluntarily Issues Recall of 50mg Losartan Potassium Tablets Due to Failed Dissolution Specifications
- Avet Pharmaceuticals Voluntarily Issues Recall of 100mg Losartan Potassium Tablets Due to Failed Dissolution Specifications
April 17, 2020
April 15, 2020
- Amneal Pharmaceuticals, LLC. Issues Voluntary Nationwide Recall of Nizatidine Oral Solution, 15 mg/mL, Due to Potential Levels of N-nitrosodimethylamine (NDMA) Impurity Amounts Above the Levels Established by FDA
- International Laboratories, LLC Issues Voluntary Nationwide Recall of One (1) Lot of Clopidogrel Tablets USP, 75 mg Packaged in Bottles of 30 Tablets Due to Mislabeling NDC # 54458-888-16; Lot # 117099A
April 9, 2020
April 3, 2020
April 1, 2020
March 27, 2020
- Dr. Reddy’s Laboratories Issues Voluntary Nationwide Recall of Phytonadione Injectable Emulsion USP, 10 mg/mL Single-Dose Ampules Due To Ampules Breaking And Shattering Upon Opening
- Antibiotic Recalled
- Stimulant Patches Recalled
March 24, 2020
March 20, 2020
March 13, 2020
March 5, 2020
February 28, 2020
February 27, 2020
February 24, 2020
February 21, 2020
- Taro Pharmaceuticals U.S.A. Issues Voluntary Nationwide Recall of Phenytoin Oral Suspension USP, 125 mg/5ml Due to Possible Underdosing or Overdosing
- Cholesterol, Blood Pressure Med Recalled
- Antibiotic Recalled
February 14, 2020
February 13, 2020
February 12, 2020
January 31, 2020
- Antacid Recalls Grow
- Efficient Laboratories, Inc. Issues Voluntary Nationwide Recall of Rompe Pecho EX, Rompe Pecho CF, and Rompe Pecho MAX due to Microbial Contamination